--- title: "Primary Blood Grouping Managed Service" ocid: "ocds-h6vhtk-02eba2" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02eba2" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02eba2.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02eba2.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "NHS BLOOD AND TRANSPLANT" published: "2021-10-14" --- # Primary Blood Grouping Managed Service Buyer: NHS BLOOD AND TRANSPLANT Current stage: Planning OCID: ocds-h6vhtk-02eba2 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02eba2) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02eba2.json) ## Summary The NHS Blood and Transplant is planning to procure a "Primary Blood Grouping Managed Service," focusing on high-throughput blood and non-blood group testing equipment. This procurement falls under the services category, specifically within the testing and evaluation industry. It is primarily aimed at manufacturers or economic operators capable of providing an automated integrated solution. Interested parties should submit their expressions of interest by 12:00 hours on 27 October 2021, as part of the planning stage of this process. This tender presents an opportunity for businesses specialising in medical equipment manufacturing, particularly those with capabilities in blood analysers, automation systems, and blood-testing reagents. Companies that align with the outlined requirements, including provision of comprehensive testing solutions and adherence to UK health regulations, are well-positioned to compete. With an estimated value of £30 million and a significant annual testing throughput of approximately 1.5 million donations, this project represents a substantial business opportunity in the healthcare sector. ## Notice This Prior Information Notice (PIN) follows 2020/S 247-615598 released on the 15 December 2020 and all information herein supersedes that of 2020/S 247-615598.This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to consult the market to improve NHSBT's knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available automated, high-throughput blood and non-blood group testing equipment and gauge market interest in a new provision of this service. It is the intention of NHSBT to further consult and engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements. ### Lot Information Lot 1 NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE. The testing equipment should also be compatible with NHSBT's manufactured reagents and where possible, with those from third party reagent suppliers.NHSBT require a high throughput blood and non-blood donation screening for primary blood grouping testing system(s), for ABO and Rh D typing (as a minimum DIV, DV and DVI), antibody screening and red cell phenotyping including Rh for donor blood samples.As a minimum, the test system supplied must be capable of undertaking the testing of blood and non-blood donor samples and providing accurate results for the following:* ABO group* Rh phenotype D, C, c, E, e * Kell * Atypical antibody screen* High titre anti-A and anti-B screening* Red cell phenotypes S, s, Jka, Jkb (test system should include an option of Cw and M)All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors.The annual estimated throughput of the NHSBT primary automated blood sample testing equipment tests approximately 1,500,000 donations (of which ca. 1500 - 2100 are non-blood donors) are tested per annum across two NHSBT testing sites, namely Manchester and Filton. Expressions of interest should be e-mailed to paul.jones@nhsbt.nhs.uk by no later than 1200 hours on 27 October 2021. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/025653-2021 | | Notice type | Planning Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 14 Oct 2021 | | Submission deadline | Not specified | | Future notice date | 13 Oct 2021 | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £30,000,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planned | | Lots status | Planned | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS BLOOD AND TRANSPLANT | | Locality | BRISTOL | | Post town | Bristol | | Postcode | BS34 7QH | | Country | England | | ITL 1 | TLK South West (England) | | ITL 2 | TLK5 West of England | | ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire | | Local authority | South Gloucestershire | | Electoral ward | Filton | | Westminster constituency | Filton and Bradley Stoke | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products - 38 - Laboratory, optical and precision equipments (excl. glasses) - 48 - Software package and information systems - 71 - Architectural, construction, engineering and inspection services - 73 - Research and development services and related consultancy services - 85 - Health and social work services ### Codes - 33696200 - Blood-testing reagents - 38434520 - Blood analysers - 48921000 - Automation system - 71632000 - Technical testing services - 73430000 - Test and evaluation - 85111810 - Blood analysis services ## Release History - 14 Oct 2021 at 08:31 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/025653-2021 ## Notice URLs - http://health.atamis.co.uk - https://www.nhsbt.nhs.uk/ - https://www.transfusionguidelines.org/red-book ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02eba2. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02eba2.json.